ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Mysoline® 250 mg Tabletten:Curatis AG
Vollst. FachinformationDDDÄnderungen anzeigenDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
N03AA03 - PrimidoneATC-DDD Version 2016. Source: WHO
N - Nervous System
 
N03 - Antiepileptics
 
N03A - Antiepileptics

This group comprises preparations used in the treatment of epilepsy.
Combined preparations are classified at separate 5th levels using the corresponding 50-series.
The group is subdivided according to chemical structure.

The DDDs for the antiepileptics are based on combination therapy.

N03AA - Barbiturates and Derivatives

Barbiturates used mainly as hypnotics/sedatives are classified in N05C - Hypnotics and sedatives.
Phenobarbital, which is used both as an antiepileptic and as a sedative, is classified in this group.
Combinations with phenytoin are classified in N03AB.

N03AA03 - Primidone
StärkeAdm.RouteNote
 O 
2024 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home